Manufacturing

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

Results of a Phase II clinical trial reveal that stem-cell transplantation treatment following complete immune system destruction increases the duration of long-term remission in patients with multiple sclerosis.

New Aggressive Treatment Shown to Halt Symptoms of Multiple Sclerosis for a Prolonged Period

The Cell and Gene Therapy Catapult released a review of their third annual survey of GMP cell and gene therapy facilities in the United Kingdom.

Report Shows Increase in Capacity in Cell and Gene Therapy Manufacturing in the UK

The National Institute of Health will conduct an internal review of the National Cancer Institute’s cell manufacturing facilities, which will affect multiple Kite projects.

Kite Pharma Pauses Selected Clinical Trials

The pharma company revealed in a fourth quarter call that it will improve its cell-culture capabilities by focusing on the use of naïve, highly proliferative cells to manufacture its CAR-T drug candidate.

Kite Pharma Stresses Importance of Cell-Culturing Techniques

The Cell Therapy Catapult, University of Birmingham, and Cancer Research Technology collaborate on CAR-T cell immuno-oncology therapy development.

UK Pharmaceutical Companies Collaborate on CAR-T Cell Immuno-oncology Therapies

TxCell signs strategic agreement with MaSTherCell for European manufacturing of its cell therapy products.

TxCell Signs Strategic Agreement with MaSTherCell

A study backed by the Centre of Regenerative Medicine found that laminins are crucial cell components that could help aid the commercial production of stem cell therapies.

Laminins Key to Production-Scale Stem Cell Development

Cell Therapy Catapult will provide manufacturing scale-up services to enable Asterias’ future clinical trials and commercial supply for Asterias’ allogeneic dendritic cell immunotherapy, AST-VAC2.

Cell Therapy Catapult to Develop Process for Asterias Biotherapeutics

The Cell History File is designed as a “cell passport” for developers and manufacturers of tissue- and cell-based medicinal products.

Cell Therapy Catapult Launches Cell History File

The company is in discussions with Europe’s Adaptive Pathways Group on clinical trials that would evaluate its PLX cells for the treatment of specific diseases.

Manufacturing, Cell Therapies